Winnipeg, Canada

Helen Wang

This inventor holds 1 USPTO granted patent, plus 2 CIPO patents. Top assignee: Scimar Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helen Wang. Retrieved from https://idiyas.com/inventor/helen-wang-i8th91vl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Helen Wang - Innovator in Diabetes Treatment

Introduction

Helen Wang is a prominent inventor based in Winnipeg, Canada. She has made significant contributions to the field of diabetes treatment through her innovative research and development. Her work focuses on addressing critical health issues such as prediabetes, hyperglycemia, and obesity.

Latest Patents

Helen Wang holds a patent for a hepatic insulin sensitizing substance and test meal for insulin sensitization. This invention provides methods for treating prediabetes, hyperglycemia, type 2 diabetes, AMIS syndrome, and obesity by administering HISS to patients. Additionally, her patent includes methods for diagnosing AMIS syndrome and shifting nutrient storage in meat-producing livestock to muscle rather than fat. She has 1 patent to her name.

Career Highlights

Helen Wang is associated with Scimar Ltd., where she continues to advance her research in diabetes treatment. Her work has garnered attention for its potential impact on public health and the agricultural sector.

Collaborations

Helen collaborates with W Wayne Lautt, a fellow researcher, to further enhance the effectiveness of her inventions and explore new avenues in diabetes management.

Conclusion

Helen Wang's innovative contributions to diabetes treatment highlight her dedication to improving health outcomes. Her work not only addresses critical health challenges but also paves the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…